Delivery Order SPE2DB22D3011-SPE2DB25FQ2AS
- Not listed
- The Defense Logistics Agency awarded a $18,237.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a delivery order valued at $12,775.35 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on August 5, 2025, with completion expected by August 6, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,292.70 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $17,178.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60 count) on July 21, 2025, with a completion date of July 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,593.34 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency has awarded a delivery order valued at $4,232.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with a completion date of July 31, 2025. This contract employs a firm fixed-price arrangement with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $33,624.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters, where it maintains significant pharmaceutical distribution operations supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2ASDelivery Order
The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive capability in delivering both brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 7/30/25 |